PRENATE Enhance NDC 75854-309

NDC codes

FDA NDC Directory

Product NDC (as listed)75854-309Labeler and product segments. Claims need a package NDC.

Product NDC at billing width75854-0309Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
75854-309-30	75854030930	30 CAPSULE, GELATIN COATED in 1 BOTTLE (75854-309-30)Marketed from Oct 16, 2013

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): PRENATE Enhance
Generic name (nonproprietary): ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, biotin, calcium carbonate, ferrous fumarate, magnesium oxide, lactic acid and doconexent
Active ingredients: Ascorbic acid — 85 mg/1Cholecalciferol — 1000 [iU]/1.alpha.-tocopherol acetate, Dl- — 10 [iU]/1Folic acid — 1 mg/1Pyridoxine hydrochloride — 25 mg/1Cyanocobalamin — 12 ug/1Biotin — 500 ug/1Calcium carbonate — 155 mg/1Ferrous fumarate — 28 mg/1Potassium iodide — 150 mg/1Magnesium oxide — 50 mg/1Doconexent — 400 mg/1
Dosage form: Capsule, Gelatin coated
Route: Oral
Labeler: Avion Pharmaceuticals, LLC
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Sep 17, 2013
Listing expires: Dec 31, 2027
Other FDA classes: Analogs/Derivatives (Chemical/Ingredient)Ascorbic Acid (Chemical structure)Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)Vitamin B 12 (Chemical structure)Vitamin B 6 (Chemical/Ingredient)Vitamin D (Chemical structure)
Identifiers: Product ID 75854-309_4f71b301-7c6e-8329-e063-6394a90ae519SPL ID 4f71b301-7c6e-8329-e063-6394a90ae519SPL set ID cf10de09-6ed5-4a66-84fa-2da4f668bbe6UNII PQ6CK8PD0R, 1C6V77QF41, WR1WPI7EW8, 935E97BOY8, 68Y4CF58BV, P6YC3EG204, 6SO6U10H04, H0G9379FGK, R5L488RY0Q, 1C4QK22F9J, 3A3U0GI71G, ZAD9OKH9JCUPC 0375854309303
Pharmacologic class: Blood Coagulation Factor; Calculi Dissolution Agent; Osmotic Laxative; Phosphate Binder; Vitamin B12; Vitamin B6 Analog; Vitamin C; Vitamin D

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N475854030930 followed by a unit qualifier and the quantity

Package 75854-0309-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 14, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS: PRENATE ® Enhance is a multivitamin/multimineral fatty acid dietary supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers. PRENATE ® Enhance can also be beneficial in improving the nutritional status of women prior to conception.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)